Using apoferritin as suitable nanocarrier for siRNA to achieve active targeting to cancer cells

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216305%3A26620%2F18%3APU129751" target="_blank" >RIV/00216305:26620/18:PU129751 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Using apoferritin as suitable nanocarrier for siRNA to achieve active targeting to cancer cells

Original language description

Small interfering RNA also known as siRNA are a short 21-23 base-pair RNA duplexes. Its leading strand is complementary to a sequence of mRNA. Interaction between mRNA and siRNA leads sequence-specific gene expression suppression, also known as RNA interference (RNAi). RNAi was first discovered in plants and later was demonstrated in Caenorhabditis elegans. Now it is known, that this mechanism can be naturally found also in mammalian cells.

Czech name

—

Czech description

—

Type

D - Article in proceedings

CEP classification

—

OECD FORD branch

30204 - Oncology

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2018

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Article name in the collection

CLINAM 2018

ISBN

—

ISSN

2296-9667

e-ISSN

—

Number of pages

2

Pages from-to

173-174

Publisher name

Neuveden

Place of publication

Neuveden

Event location

Basel

Event date

Sep 2, 2018

Type of event by nationality

WRD - Celosvětová akce

UT code for WoS article

—